Ikena Oncology Inc reports results for the quarter ended in June - Earnings Summary

ImageneBio

10/08/2023 14:39

* Ikena Oncology Inc  IKNA.OQ  reported a quarterly adjusted
loss
of 44 cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 47 cents per share.
    * Revenue rose 424.6% to $2.00 million from a year ago;
analysts
expected $3.08 million. 
    * Ikena Oncology Inc's reported EPS for the quarter was a
loss
of 44 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Ikena Oncology Inc shares had fallen by 36.0% this
quarter and
gained 57.9% so far this year.
    * The company reported a quarterly loss of $17.12 million.
    * Wall Street's median 12-month price target for Ikena
Oncology
Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 01:39 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.47          -0.44          Beat
 Mar. 31 2023      -0.47          -0.39          Beat
 Dec. 31 2022      -0.48          -0.40          Beat
 Sep. 30 2022      -0.50          -0.48          Beat